Aynur Daglar-Aday

Prognostic significance of ASXL1, JAK2V617F mutations and JAK2V617F allele burden in Philadelphia-negative myeloproliferative neoplasms

A. Yavuz, M. Nalçacı, İ. Yonal-Hindilerden, 2015, Journal of blood medicine.

Prognostic significance of ASXL 1 , JAK 2 V 617 F mutations and JAK 2 V 617 F allele burden in Philadelphia-negative myeloproliferative neoplasms

A. Yavuz, M. Nalçacı, İ. Yonal-Hindilerden, 2015 .

Investigation of BRAF V600E mutation in papillary thyroid carcinoma and tumor-surrounding nontumoral tissues.

A. Eronat, H. Yılmaz-Aydoğan, F. Aksoy, 2013, DNA and cell biology.

The impact of CYP2D6*4 and GSTP1 Ile105Val polymorphisms on the susceptibility to develop BCR-ABL1 negative myeloproliferative neoplasms

A. Yavuz, H. Yılmaz-Aydoğan, O. Ozturk, 2020, Molecular Biology Reports.

The effects of age and gender on the relationship between HMGCR promoter-911 SNP (rs33761740) and serum lipids in patients with coronary heart disease.

Z. Bugra, H. Yılmaz-Aydoğan, E. Coskunpinar, 2013, Gene.

The Burden of JAK2V617F Mutated Allele in Turkish Patients With Myeloproliferative Neoplasms

A. Yavuz, M. Nalçacı, İ. Yonal-Hindilerden, 2014, Journal of clinical medicine research.

The Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis

A. Yavuz, M. Nalçacı, F. Hindilerden, 2015, Journal of clinical medicine research.

Interactive effects of interferon-gamma functional single nucleotid polymorphism (+874 T/A) with cardiovascular risk factors in coronary heart disease and early myocardial infarction risk

H. Yılmaz-Aydoğan, Aynur Daglar-Aday, O. Kucukhuseyin, 2020, Molecular Biology Reports.

Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis

A. Yavuz, F. Sargın, M. Nalçacı, 2016, Turkish journal of haematology : official journal of Turkish Society of Haematology.